Perfil
Peter Clinton is currently a Director at Amprion, Inc. He previously worked as an Acting Chief Executive Officer at Cricket Wellington, Inc. from 2011 to 2012.
Cargos activos de Peter Clinton
Empresas | Cargo | Inicio |
---|---|---|
Amprion, Inc.
Amprion, Inc. Medical SpecialtiesHealth Technology Amprion, Inc. is a company based in San Diego, CA that specializes in biomarker testing for brain diseases. The American company's Syntap® biomarker test aids physicians in the clinical diagnosis of Parkinson's disease, Lewy body dementia, and Alzheimer's disease. The test identifies misfolded synuclein aggregates, a hallmark in various neurodegenerative diseases. Amprion plans to launch other biomarker tests to detect Alzheimer's in early stages. The company was founded in 2006 by Claudio Soto and Russ M. Lebovitz, who has been the CEO since then. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Peter Clinton.
Empresas | Cargo | Fin |
---|---|---|
Cricket Wellington, Inc. | Director Ejecutivo | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Cricket Wellington, Inc. | |
Amprion, Inc.
Amprion, Inc. Medical SpecialtiesHealth Technology Amprion, Inc. is a company based in San Diego, CA that specializes in biomarker testing for brain diseases. The American company's Syntap® biomarker test aids physicians in the clinical diagnosis of Parkinson's disease, Lewy body dementia, and Alzheimer's disease. The test identifies misfolded synuclein aggregates, a hallmark in various neurodegenerative diseases. Amprion plans to launch other biomarker tests to detect Alzheimer's in early stages. The company was founded in 2006 by Claudio Soto and Russ M. Lebovitz, who has been the CEO since then. | Health Technology |
- Bolsa de valores
- Insiders
- Peter Clinton